Legend Biotech Corp
LEGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001801198
In the last 90 days, Legend Biotech Corp insiders filed 0 open-market purchases and 1 sale; 219 institutions reported holding it in 13F filings for Q2 2026, worth $2.98B in total; HHLR Advisors (Hillhouse) is the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Legend Biotech Corp changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 151 | 159 | +8 |
| Shares | 52.7M | 63.8M | +11.1M (+21.1%) |
| Value | $2.90B | $2.60B | −$295.6M (−10.2%) |
New holders (25)
Institutions that held Legend Biotech Corp at the end of Q3 2022 but not at the end of Q2 2022.
Sold out (17)
Institutions that held Legend Biotech Corp at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Avidity Partners Management LP | 1,000,000 | $55.0M |
| Baker Bros. Advisors LP | 856,658 | $47.1M |
| Iron Triangle Partners LP | 495,329 | $27.2M |
| FengHe Fund Management Pte. Ltd. | 475,263 | $26.1M |
| Driehaus Capital Management LLC | 317,117 | $17.4M |
| Allianz Asset Management GmbH | 252,464 | $13.9M |
| Ardsley Advisory Partners LP | 81,000 | $4.46M |
| Voloridge Investment Management, LLC | 55,673 | $3.06M |
| National Bank of Canada | 25,200 | $1.39M |
| Cinctive Capital Management LP | 20,000 | $1.10M |
| Capital Fund Management S.A. | 16,495 | $907.2K |
| JustInvest LLC | 5,514 | $303.0K |
| Voya Investment Management LLC | 4,782 | $263.0K |
| ProShare Advisors LLC | 4,149 | $228.0K |
| Nomura Holdings Inc | 3,957 | $215.0K |
| FNY Investment Advisers, LLC | 1,034 | $56.0K |
| State of Wyoming | 171 | $9.00K |